Aravive Inc. (ARAV) Climbs 80% After Positive Data from Ongoing Trial of AVB-500 in Ovarian Cancer

November 20, 2019 7:21 AM
Aravive Inc. (NASDAQ: ARAV) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Hot FDA News Trader Talk

Next Articles